Efficient Targeted Next Generation Sequencing-Based Workflow for Differential Diagnosis of Alport-Related Disorders
Authors:
Open Access
- 2 March 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (3) , e0149241
Abstract
Alport syndrome (AS) is an inherited type IV collagen nephropathies characterized by microscopic hematuria during early childhood, the development of proteinuria and progression to end-stage renal disease. Since choosing the right therapy, even before the onset of proteinuria, can delay the onset of end-stage renal failure and improve life expectancy, the earliest possible differential diagnosis is desired. Practically, this means the identification of mutation(s) in COL4A3-A4-A5 genes. We used an efficient, next generation sequencing based workflow for simultaneous analysis of all three COL4A genes in three individuals and fourteen families involved by AS or showing different level of Alport-related symptoms. We successfully identified mutations in all investigated cases, including 14 unpublished mutations in our Hungarian cohort. We present an easy to use unified clinical/diagnostic terminology and workflow not only for X-linked but for autosomal AS, but also for Alport-related diseases. In families where a diagnosis has been established by molecular genetic analysis, the renal biopsy may be rendered unnecessary.Keywords
This publication has 38 references indexed in Scilit:
- Targeted Exome Sequencing Integrated with Clinicopathological Information Reveals Novel and Rare Mutations in Atypical, Suspected and Unknown Cases of Alport Syndrome or ProteinuriaPLOS ONE, 2013
- Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research CollaborativePediatric Nephrology, 2012
- The Alport syndrome COL4A5 variant databaseHuman Mutation, 2010
- Novel heterozygous COL4A3 mutation in a family with late-onset ESRDPediatric Nephrology, 2010
- Dominant-negative Effects of COL7A1 Mutations Can be Rescued by Controlled Overexpression of Normal Collagen VIIJournal of Biological Chemistry, 2009
- Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuriaKidney International, 2007
- Primer3Plus, an enhanced web interface to Primer3Nucleic Acids Research, 2007
- Identification of a new mutation in the α4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemiaNephrology Dialysis Transplantation, 2001
- Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndromeKidney International, 2001
- Estimating prevalence in single-gene kidney diseases progressing to renal failureKidney International, 2000